サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血球計数装置の世界市場2023-2030
市場調査レポート
商品コード
1270938

血球計数装置の世界市場2023-2030

Global Hematology Analyzer Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血球計数装置の世界市場2023-2030
出版日: 2023年05月01日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血球計数装置の世界市場規模は、2022年に73億米ドルとなり、予測期間（2023-2030年）にCAGR6.6%を記録して、2030年には115億米ドルに達すると予測されます。血球計数装置は、血液サンプルに含まれるさまざまな種類の赤血球や白血球、血小板、ヘモグロビン、ヘマトクリット値の数を数える、コンピュータ化された高度な専門機械です。基準範囲外の結果を表示するためのプログラム可能な自動アラームシステムを備えています。血球計数装置は、病気の検出、モニタリング、予後予測、スクリーニングに関係し、血友病、血液がん、血栓など血液に関するさまざまな病気に広く使用されています。また、白血病、貧血、輸血、悪性リンパ腫など、血液学的診断が行われる疾患も含まれます。

貧血、血液がん、出血性疾患、血液中の感染症などの血液疾患の有病率の上昇は、市場の成長を促進する大きな要因となっています。さらに、血球計数装置の技術的進歩、自動化された血球計数装置の需要の増加、高感度血球計数装置への嗜好の高まりが、血球計数装置市場の成長をさらに後押ししています。しかし、高度な機能と自動化に起因する血球計数装置の高コストが、市場の成長を阻害する可能性があります。一方、新興国での成長機会は、血球計数装置市場のプレーヤーに有利な機会を提供すると予想されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長性の展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの見解と現在の市場動向
    • 主要な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 血球計数装置の世界市場：製品・サービス別
    • インストゥルメント
    • 試薬・消耗品
    • サービス
  • 血球計数装置の世界市場：タイプ別
    • 完全自動化
    • 半自動化
  • 血液学アナライザーの世界市場：エンドユーザー別
    • 病院
    • 臨床検査室
    • 研究機関
    • その他

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • Accurex Biomedical Pvt. Ltd.
  • Analyticon Biotechnologies GmBH
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Danaher Corp.
  • F Hoffmann-La Roche Ltd.
  • Horiba, Ltd.
  • Nihon Kohden Corp.
  • Ortho Clinical Diagnostics
  • Perlong Medical Equipment Co., Ltd.
  • Siemens Healthcare GmBH
  • Stratec SE
  • Sysmex Corp.
図表

LIST OF TABLES

  • 1. GLOBAL HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT AND SER-VICE, 2022-2030 ($ MILLION)
  • 2. GLOBAL HEMATOLOGY ANALYZER BY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HEMATOLOGY ANALYZER BY REAGENTS AND CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HEMATOLOGY ANALYZER BY SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 6. GLOBAL FULLY AUTOMATED HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SEMI-AUTOMATED HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 9. GLOBAL HEMATOLOGY ANALYZER FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY RE-GION, 2022-2030 ($ MILLION)
  • 10. GLOBAL HEMATOLOGY ANALYZER FOR CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL HEMATOLOGY ANALYZER FOR RESEARCH INSTITUES MARKET RESEARCH AND ANALY-SIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL HEMATOLOGY ANALYZER FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT AND SERVICE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT AND SERVICE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT AND SERVICE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUN-TRY, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT AND SERVICE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD HEMATOLOGY ANALYZER MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HEMATOLOGY ANALYZER MARKET SHARE BY PRODUCT AND SERVICE, 2022 VS 2030 (%)
  • 2. GLOBAL HEMATOLOGY ANALYZER BY INSTRUMENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL HEMATOLOGY ANALYZER BY REAGENTS AND CONSUMABLES MARKET SHARE BY RE-GION, 2022 VS 2030 (%)
  • 4. GLOBAL HEMATOLOGY ANALYZER BY SERVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL HEMATOLOGY ANALYZER MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 6. GLOBAL FULLY-AUTOMATED HEMATOLOGY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SEMI-AUTOMATED HEMATOLOGY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL HEMATOLOGY ANALYZER MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 9. GLOBAL HEMATOLOGY ANALYZER FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL HEMATOLOGY ANALYZER FOR CLINICAL LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL HEMATOLOGY ANALYZER FOR RESEARCH INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL HEMATOLOGY ANALYZER FOR OTHER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL HEMATOLOGY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD HEMATOLOGY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027258

The global hematology analyzer market size was valued at $7.3 billion in 2022, and is projected to reach $11.5 billion by 2030, registering a CAGR of 6.6% during the forecast period (2023-2030). Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample. They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with detection, monitoring of diseases, prognosis and subsequent screening and are extensively used against various blood related diseases such as hemophilia, blood cancer and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.

Rising prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, is a major factor that drives the growth of the market. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzers coupled with rising preference toward high sensitivity hematology analyzers further fuel the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hinder the growth of the market. In contrast, growth opportunities in emerging economies are expected to offer lucrative opportunities for players in the hematology analyzer market.

Segmental Outlook:

The global hematology analyzer market is segmented into product and services, type, and end-users. Based on product & service, it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully-automated hematology analyzer and semi-automated hematology analyzer. Based on the end user, the market is further sub-segmented into hospitals, clinical laboratories, research institutes, and others. Among the application segment, the fully-automated sub-segment is expected to cater prominent market share over the forecast period. Among product and services, the reagent & consumables market is expected to hold a significant market share due to increasing adoption of reagent and consumables in clinical laboratories for blood cell counts, coagulation testing, other hematology tests, control, and calibration.

The Fully-Automated Sub-Segment Is Anticipated To Hold Prominent Share in the Global Hematology Analyzer Market

Among type, fully automated segment is expected to hold a prominent share in the market during the forecast period. This is attributed to growing preference for automated hematology instruments, along with increasing technological advancements, and the combination of basic flow-cytometry techniques in automated hematology analyzers. Furthermore, clinical laboratories segment is expected to hold considerable share throughout the forecast period owing to presence of high-quality equipment in clinical laboratories and the accurate results obtained from them.

Regional Outlooks:

The global hematology analyzer market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, the North American regional market is expected to cater prominent growth over the forecast period, owing to the increasing burden of blood disorders and the growth in the adoption of hematology analyzers by the diagnostic industry.

The Asia-Pacific Region is expected to Hold Prominent Share in the Global Hematology Analyzer Market

The Asia-Pacific region is expected to hold a prominent share in the market during the forecast period owing to opportunities offered by market key players. Furthermore, the growing healthcare infrastructure, increasing prevalence of blood diseases, rising disposable incomes, well-established presence of domestic companies, and aging population in the region are further accelerating the growth of the market. In addition, factors such as increase in population and growth in the economies of developing countries such as India and China, are also supporting the growth of the hematology analyzer market in Asia. Technological advancements coupled with supportive investments and funds by the government, especially in developing countries, such as India and China, are also expected to contribute to market growth.

Market Players Outlook:

The major companies serving the global hematology analyzer market include Abbott Laboratories, Horiba Ltd., Siemens Healthcare GmBH, Sysmex Corp., Danaher Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Mindray launched the BC-700 Series, a revolutionary hematology analyzer series that includes both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. Moreover, in April 2022, Sysmex Europe launched its new three-part differential system 'XQ-320 XQ-Series Automated Hematology Analyzer', answering the needs of this important high-volume market segment. XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments with reliable technology and a new level of usability. Users can get a first real impression of the new instrument at the EuroMedLab exhibition in Munich, Germany.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Hematology Analyzer Market by Product and Service
    • 4.1.1. Instruments
    • 4.1.2. Reagents and Consumables
    • 4.1.3. Services
  • 4.2. Global Hematology Analyzer Market by Type
    • 4.2.1. Fully Automated
    • 4.2.2. Semi-Automated
  • 4.3. Global Hematology Analyzer Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Clinical Laboratories
    • 4.3.3. Research Institutes
    • 4.3.4. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Accurex Biomedical Pvt. Ltd.
  • 6.3. Analyticon Biotechnologies GmBH
  • 6.4. Beckman Coulter Inc.
  • 6.5. Bio-Rad Laboratories, Inc.
  • 6.6. Boule Diagnostics AB
  • 6.7. Danaher Corp.
  • 6.8. F Hoffmann-La Roche Ltd.
  • 6.9. Horiba, Ltd.
  • 6.10. Nihon Kohden Corp.
  • 6.11. Ortho Clinical Diagnostics
  • 6.12. Perlong Medical Equipment Co., Ltd.
  • 6.13. Siemens Healthcare GmBH
  • 6.14. Stratec SE
  • 6.15. Sysmex Corp.